Everything Your Parents Never Told You About PSUR
Ensure Clinical Trials Proceed Apace by Connecting Patient, Site, Demographic, and Principal Investigator Data
Bassil Akra, Ph.D.
Marta Carnielli, Pharm.D.
Robert Kovelman, Ph.D
Published Online: 14 October 2022
What’s in the Webinar?
n Mid-December of 2022, the Medical Device Coordination Group. (MDCG) released the much-anticipated Guidance (MDCG 2022-21) on Periodic Safety Update Report (PSUR).
To help manufacturers to interpret the new PSUR Guidance, Huma.AI assembled an expert panel of EU MDR and IVDR leaders from notified bodies and industry consultants to discuss the real-life implications of the guidance for manufacturers.
Disclaimer: The views and opinions expressed in this webinar are those of the speakers and do not necessarily reflect the views or positions of any entities they represent, nor shall they be construed as endorsements of any entity or sponsor.